|
AltAssets is the private equity news and research service from Almeida Capital
|
|
|
PRINT THIS PAGE German firm SHS holds first closing on third life sciences, healthcare fund09/04/2008. Source: AltAssets. 
Tübingen-based SHS Gesellschaft für Beteiligungsmanagement has held a first closing on its third fund. The firm has now raised €40m for its SHS III fund, which is expected to close on €70m by the end of this year. Investors from Germany and across Europe have contributed to the fund. They include the European Investment Fund, through its European Recovery Programme (ERP)-EIF Dachfonds and the Competitiveness and Innovation Framework Programme, set up by the European Union; the Kreditanstalt für Wiederaufbau and various entrepreneurs, family offices and the SHS management team, which is committing five per cent of the capital raised at first closing to the fund.
SHS III will invest in companies operating in the areas of life sciences and healthcare and based in Germany, Austria or Switzerland.
SHS has a particular focus on areas including medical technology and supplies, diagnostics and platform and production technologies. The firm's investments to date have included VITA 34, ProBioGen and Novosis.
SHS recently appointed Stephan Rapp as a new senior manager. Prio to SHS, Rapp was business development manager and managing director at the blood donation service of the Bavarian Red Cross.
Copyright © 2008 AltAssets
|
 
|
|
|
